Correlation of Mutational Burden Detected by Targeted Next -Generation Sequencing with Pathological Disease Burden in Hematological Malignancies.

Kang S. L.; Arboleda V. A.; Lee T. D.; Xian R. R.

首页> 外文期刊>The Journal of molecular diagnostics: JMD >Correlation of Mutational Burden Detected by Targeted Next -Generation Sequencing with Pathological Disease Burden in Hematological Malignancies.

【24h】

Correlation of Mutational Burden Detected by Targeted Next -Generation Sequencing with Pathological Disease Burden in Hematological Malignancies.

机译：血液学恶性肿瘤病理疾病负担检测到靶向下一结论检测的突变负担的相关性。

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《The Journal of molecular diagnostics: JMD》 |2017年第6期|共1页
作者
Kang S. L.; Arboleda V. A.; Lee T. D.; Xian R. R.;
展开▼
作者单位

Univ Calif Los Angeles Los Angeles CA USA;

Univ Calif Los Angeles Los Angeles CA USA;

Univ Calif Los Angeles Los Angeles CA USA;

Univ Calif Los Angeles Los Angeles CA USA;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类临床医学;
关键词

相似文献

外文文献
中文文献
专利

1. Correlation of Mutational Burden Detected by Targeted Next -Generation Sequencing with Pathological Disease Burden in Hematological Malignancies. [J] . Kang S. L., Arboleda V. A., Lee T. D., The Journal of molecular diagnostics: JMD . 2017,第6期

机译：血液学恶性肿瘤病理疾病负担检测到靶向下一结论检测的突变负担的相关性。
2. Determination of IDH1 Mutational Burden and Clearance Via Next-Generation Sequencing in Patients with IDH1 Mutation-Positive Hematologic Malignancies Receiving AG-120, a First-in-Class Inhibitor of Mutant IDH1 [J] . DiNardo Courtney D., de Botton Stephane, Stein Eytan M., Blood: The Journal of the American Society of Hematology . 2016,第22期

机译：IDH1突变阳性血液系统恶性肿瘤接受AG-120（突变IDH1的第一个抑制剂）的患者通过下一代测序确定IDH1突变的负担和清除率
3. High Yield of RNA Sequencing for Targetable Kinase Fusions in Lung Adenocarcinomas with No Mitogenic Driver Alteration Detected by DNA Sequencing and Low Tumor Mutation Burden [J] . Ryma Benayed, Michael Offin, Kerry Mullaney, Clinical cancer research: an official journal of the American Association for Cancer Research . 2019,第15期

机译：肺腺癌靶向激酶融合的高产量RNA测序，DNA测序和低肿瘤突变负荷检测肺腺癌中的肺腺癌融合
4. Predictive Efficacy of Low Burden EGFR Mutation Detected by Next-Generation Sequencing on Response to EGFR Tyrosine Kinase Inhibitors in Non-Small-Cell Lung Carcinoma [C] . Yeul Hong Kim, Hye Sook Kim, Jae Sook Sung, Molecular Medicine TRI-CON. . 2014

机译：下一代测序对非小细胞肺癌抗蛋白酶激酶抑制剂进行下一代测序检测的低负荷EGFR突变的预测疗效
5. Targeting RAS Palmitoylation in BCR-ABL Mediated Hematological Malignancies. [D] . Stropkay, Craig. 2013

机译：在BCR-ABL介导的血液系统恶性肿瘤中靶向RAS棕榈酰化。
6. Correction to: Use of an Integrated Pan-Cancer Oncology Enrichment Next-Generation Sequencing Assay to Measure Tumour Mutational Burden and Detect Clinically Actionable Variants [O] . Valerie Pestinger, Matthew Smith, Toju Sillo, -1

机译：校正至：使用整合的全癌基因富集的下一代测序测定法来测量肿瘤突变负担并检测临床上可行的变异体
7. Correction to: Use of an Integrated Pan-Cancer Oncology Enrichment Next-Generation Sequencing Assay to Measure Tumour Mutational Burden and Detect Clinically Actionable Variants [O] . Valerie Pestinger, Matthew Smith, Toju Sillo, 2020

机译：校正至：使用集成的泛癌肿瘤学富集下一代测序测定测量肿瘤突变负担并检测临床可行的变体

Correlation of Mutational Burden Detected by Targeted Next -Generation Sequencing with Pathological Disease Burden in Hematological Malignancies.

著录项

相似文献

相关主题

期刊订阅